Endocrinology News and Research

Latest Endocrinology News and Research

Telephone helps reduce diabetes health disparities and improves health outcomes

In this high-tech world of electronic communications, the older, reliable form of communication via the telephone has proven effective in reaching out to older African-American women with diabetes.

18 Jul 2005

Cultural and language barriers may be hindering the treatment of South Asians with diabetes

South Asians are four times more likely than the rest of the UK population to have the condition. A follow up study has now begun into finding our how communication barriers could be overcome in medical consultation.

17 Jul 2005

New compound ruboxistaurin may decrease vision loss in diabete

A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes.

15 Jul 2005

Growing body of evidence indicating that childhood obesity is linked to a lack of exercise

A study published by the medical journal The Lancet dealt another blow to the "food police" and the trial lawyers seeking to blame food for the nation's expanding waistline.

15 Jul 2005

Consumer group wants health warnings on soft drinks

The Center for Science in the Public Interest (CSPI), a U.S. consumer group, are petitioning the Food and Drug Administration (FDA) for warnings to be placed on soft drinks in order to alert consumers of the dangers of too much sugar.

14 Jul 2005

A new study shows that the number of Americans who had weight-loss surgery quadrupled between 1998 and 2002

A new study shows that the number of Americans who had weight-loss surgery quadrupled between 1998 and 2002.

13 Jul 2005

Metabolic syndrome prevented by a fit heart

According to a new study, a person's cardiorespiratory fitness is a strong predictor of their risk of developing metabolic syndrome.

12 Jul 2005

EU upholds food supplement ban - rejects appeal by health groups

The European Court of Justice has upheld a controversial law which could ban hundreds of vitamin and mineral supplements from being sold in Britain.

12 Jul 2005

Sirna Therapeutics granted new UK patents

Sirna Therapeutics has announced that the United Kingdom (UK) Patent Office has granted the Company two additional short interfering RNA (siRNA) target patents. The first patent covers any siRNA with one or more chemical modifications targeting Vascular Endothelial Growth Factor (VEGF).

12 Jul 2005

Outer lining of the umbilical cord is a rich source of stem cells

CellResearch Corporation in Singapore and its team of scientists, headed by Chief Scientist, Dr Phan Toan Thang, have recently made a revolutionary discovery: that the outer lining of the umbilical cord is a rich source of stem cells.

12 Jul 2005

Obese men may not process carbohydrates as efficiently as obese women

Obese men may not process carbohydrates as efficiently as obese women, a condition that can, ultimately, lead to a decrease in fitness level and the development of metabolic disorders.

12 Jul 2005

Giving oxygen may do more harm than good

Doctors and paramedics who give their patients oxygen - the most commonly administered "drug" in the world - may be doing more harm than good, a Queen's University researcher contends.

11 Jul 2005

New understanding of degeneration of brain cells in patients with Alzheimer's, Huntington's, and Parkinson's diseases

A ground-breaking new research approach to understanding the cellular processes of Alzheimer's and other degenerative diseases has revealed a promising pathway to the development of new types of drugs for these diseases.

11 Jul 2005

Obese men may not process carbohydrates as efficiently as obese women

A new study published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), showed that severely obese men were more carbohydrate intolerant and had less physical endurance than severely obese women, leading researchers to believe that gender plays a strong role in physical fitness and a person's ability to metabolize carbohydrates.

11 Jul 2005

Newly discovered gene mutation may account for many cases of immune deficiency

...in particular two syndromes known as immunoglobulin A (IgA) deficiency and Common Variable Immunodeficiency (CVID), report researchers in the July issue of Nature Genetics. The discovery may lead to a new diagnostic test for these conditions, which make people highly susceptible to infections and often go unrecognized because of a lack of good tests.

11 Jul 2005

Low dose birth control pill raises heart attack risk, especially in some women

A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.

11 Jul 2005

Fat adults more likely to have increased insulin resistance, a risk marker for Type 2 diabetes

Adult lifestyle has more influence on your chances of developing diabetes than childhood experience, according to new research whose findings contradict previously-held beliefs.

6 Jul 2005

Discovery of genes that impact the development and function of blood stem cells

Researchers at the University of Minnesota have identified for the first time a group of genes that impact the development and function of blood stem cells, a discovery that brings researchers a step closer to harnessing the power of stem cells for disease treatments.

6 Jul 2005

Obese older women may be more prone to frailty

Obesity is associated with frailty in obese older women, according to a recent study published in the Journal of the American Geriatrics Society.

6 Jul 2005

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

30 Jun 2005